(Q39843996)

15 September 2017

Active surveillance for the management of prostate cancer in a contemporary cohort (English)

1 reference

15 September 2017

1 reference

Matthew R Cooperberg

6

0 references

author name string

Marc A Dall'Era

1

1 reference

15 September 2017

Badrinath R Konety

2

1 reference

15 September 2017

Janet E Cowan

3

1 reference

15 September 2017

Katsuto Shinohara

4

1 reference

15 September 2017

Frank Stauf

5

1 reference

15 September 2017

Maxwell V Meng

7

1 reference

15 September 2017

Christopher J Kane

8

1 reference

15 September 2017

Nanette Perez

9

1 reference

15 September 2017

Viraj A Master

10

1 reference

15 September 2017

Peter R Carroll

11

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

15 September 2017

1 reference

15 September 2017

112

1 reference

15 September 2017

2664-2670

1 reference

15 September 2017

12

1 reference

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

Active surveillance with selective delayed intervention for favorable risk prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

Long-term survival among men with conservatively treated localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

National practice patterns and time trends in androgen ablation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

ACTIVE SURVEILLANCE WITH SELECTIVE DELAYED INTERVENTION: USING NATURAL HISTORY TO GUIDE TREATMENT IN GOOD RISK PROSTATE CANCER

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Increased accuracy of biopsy Gleason score obtained by extended needle biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Delayed versus immediate surgical intervention and prostate cancer outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Predictors of histological disease progression in untreated, localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Uncertainty intervention for watchful waiting in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23502

7 January 2021

Identifiers

DOI

10.1002/CNCR.23502

1 reference

15 September 2017

1 reference